Cyclic adenosine monophosphate-dependent vascular responses to purinergic agonists adenosine triphosphate and uridine triphosphate in the anesthetized mouse

Journal of Cardiovascular Pharmacology

Volumn 39, Issue 1, 2002, Pages 142-149

  Shah, M K ^a   Kadowitz, P J ^a  

^a NONE   (United States)

Author keywords

cAMP; Cardiovascular effects; Purinergics

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; ADENYLATE CYCLASE; ARACHIDONIC ACID; BRADYKININ; CYCLIC AMP; CYCLIC GMP; MECLOFENAMATE SODIUM; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; PURINE RECEPTOR; PURINERGIC RECEPTOR AFFECTING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID TETRASODIUM; ROLIPRAM; SALBUTAMOL; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE; ZAPRINAST;

ANESTHESIA; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; VASODILATATION;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ADENOSINE TRIPHOSPHATE; ANESTHESIA; ANIMALS; BLOOD PRESSURE; CYCLIC AMP; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; MECLOFENAMIC ACID; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PURINONES; PYRIDOXAL PHOSPHATE; RECEPTORS, PURINERGIC P2; ROLIPRAM; URIDINE TRIPHOSPHATE; VASODILATION;

EID: 0036138081     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200201000-00015     Document Type: Article

References (30)

1. P2 purinoceptors on vascular endothelial cells: Physiological and transduction mechanisms
2. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides
3. Extracellular ATP in the regulation of renal microvascular function
4. Receptors for purines and pyrimidines
5. A basis for distinguishing two types of purinergic receptor
6. Purinoceptors: Are there families of P2X and P2Y purinoceptors?
7. Roles of P2-purinoceptors in the cardiovascular system
8. P2x purinoceptors in the feline pulmonary vascular bed: Distribution and selective in vivo pharmacological probes
9. Effects of purines and pyrimidines on the rat mesenteric arterial bed
10. Mechanisms of coronary vasodilatation produced by ATP in guinea-pig isolated perfused heart
11. Discrimination by PPADS between endothelial-P2Y and P2U-purinoceptors in the rat isolated mesenteric arterial bed
12. The effects of adenosine triphosphate and related purines on arterial resistance vessels in vitro and in vivo
13. Newly evidenced pyrimidinoceptors and the P2x purinoceptors are present on the vascular smooth muscle and respectively mediate the UTP and ATP induced contractions of the dog maxillary internal vein
14. Pharmacological analysis of responses to ATP in the isolated and perfused canine coronary artery
15. Mechanisms by which extracellular ATP and UTP stimulate the release of prostacyclin from bovine pulmonary artery endothelial cells
16. Involvement of inositol 1,4,5-triphosphate and calcium in the action of adenine nucleotides on aortic endothelial cells
17. Hyperpolarization and relaxation of resistance arteries in response to adenosine diphosphate
18. Phosphorylation and activation of p42 and p44 mitogen-activated protein kinase are required for the P2 purinoceptor stimulation of endothelial prostacyclin production
19. ATP activates K and Cl channels via purinoceptor-mediated release of Ca2+ in human coronary artery smooth muscle
20. P2 purinoceptor-mediated cyclic AMP accumulation in bovine vascular smooth muscle cells
21. Effects of ATP on cultured smooth muscle cells from rat aorta
22. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: Identification of a UDP-selective, a UTP-selective, and an ATP-and UTP-selective receptors
23. Characterization of P2 receptors for purine and pyrimidine nucleotides in human placental cotyledons
24. Regulation of histamine and UTP induced increases in Ins (1,4,5)P3, Ins (1,3,4,5)P4 and Ca2+ by cyclic AMP in DDT1 MF-2 cells
25. Role of the intima in cholinergic and purinergic relaxation of isolated canine femoral arteries
26. Stimulation of vascular prostacyclin synthesis by extracellular ADP and ATP
27. P2 purinergic receptor agonists enhance cAMP production in Madin-Darby canine kidney epithelial cells via an autocrine/paracrine mechanism
28. PPADS: An antagonist at endothelial P2y-purinoceptors but not to P2u-purinoceptors
29. PPADS, a novel functionally selective antagonist of P2 purinoceptor-mediated responses
30. Discrimination by PPADS between endothelial P2y and P2u purinoceptors in the rat isolated mesenteric arterial bed